Form 8-K - Current report:
SEC Accession No. 0001213900-25-029000
Filing Date
2025-04-04
Accepted
2025-04-04 16:05:20
Documents
14
Period of Report
2025-04-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237208-8k_china.htm   iXBRL 8-K 26024
2 PRESS RELEASE, DATED APRIL 4, 2025 ea023720801ex99-1_china.htm EX-99.1 6590
  Complete submission text file 0001213900-25-029000.txt   211101

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20250404.xsd EX-101.SCH 3047
4 XBRL LABEL FILE cphi-20250404_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE cphi-20250404_pre.xml EX-101.PRE 22380
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0237208-8k_china_htm.xml XML 3779
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 25813960
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)